Despite this and the large variability in Pgp levels observed in ovarian cancer [70,83,86], the insensitivity of this malignancy to chemotherapy can be correlated with the expression of the mdr1 gene product [61,87-89]. This evidence concerns the gene PGP and ovarian carcinoma.